Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin and Metformin Combination in Type 2 Diabetes
NCT00975065Phase 4Completed
- Sponsor
- Handok
- Start
- Aug 2009
- Primary completion
- Dec 2011
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Handok. Primary endpoint: Hemoglobin A1c at 24 weeks. Started Aug 2009; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00975065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975065.